Browsing Institute of Health Research by Author "Abraham, J"
Now showing items 1-1 of 1
Issue Date | Title | Author(s) |
---|---|---|
6 June 2019 | 6 versus 12 months of adjuvant trastuzumab in patients with HER2 positive breast cancer (PERSEPHONE): definitive 4-year disease-free survival results of an open label randomised phase 3 non-inferiority trial. | Earl, HM; Hiller, L; Vallier, A; et al. |